Effect of absorption enhancer of borneol on ginsenoside Rg1 and the nasal ciliotoxicity

Chinese Pharmaceutical Journal

Volumn 41, Issue 4, 2006, Pages 261-264

  Chen, Xin Mei ^a   Zhu, Jia Bi ^a   Sun, Wei Dong ^b   Zhang, Li Jian ^c  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b Xinjiang Tefeng Pharmaceutical Co Ltd   (China)

^c Hongjiu Biotech Co Ltd   (China)

Author keywords

Borneol; Ginsenoside Rg1; Nasal absorption; Nasal ciliotoxicity

Indexed keywords

BORNEOL; GINSENOSIDE RG 1;

ARTICLE; CILIARY MOTILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG ABSORPTION; DRUG EFFECT; ELECTRON MICROSCOPE; ENHANCER REGION; MALE; NONHUMAN; NOSE DISEASE; NOSE MUCOSA; RAT;

EID: 33750933928     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. WANG X Y, CHEN J, ZHANG J T. Effect of ginsenoside Rg1 on learning and memory impairment induced by β-apandits mechanism of action [J]. Acta Pharm Sin 2001, 36(1):1-4.
2. LIU M, ZHANG J T. Ameliorating age-related alterations of ginsenoside Rg1 in open-field behavioral activity and motor responses in old rats [J]. Chin Pharm J 1996, 31(8):95-100.
3. SHEN L H, ZHANG J T. Ginsenoside Rg1 increases the survival rate of hippocampal neural stem cells and improves learning and memory in gerbils suffered from transient global ischemia[J]. Centr South Pharm 2004, 2(1):6-9.
4. TSUTOMU O, HISAYUKI T, YOSHIO T. Studies on absorption, distribution, excretion and metabolism of ginseng saponins. II the absorption, distribution and excretion of ginsenoside Rg1 in the rats[J]. Chem Pharm Bull, 1983, 31(1):292-298.
5. XU Q F, FANG X L, CHEN D F, et al. Studies on formulations of Panax notoginsenosides for intranasal administration [J]. Acta Pharm Sin 2003, 38(11):859-862.
6. XU Q F, FANG X L, CHEN D F. Pharmacokinetics and bioavailability of ginsenoside Rb1 and Rg1 from Panax notoginseng in rats [J]. J Ethnopharmacol, 2003, 84(2-3):187-192.
7. LISBETH I. Nasal drug deliv: new developments and strategies[J]. Drug Discov Today, 2002, 23(7):1184-1189.
8. ANWAR A H. Intranasal drug delivery [J]. Adv Drug Deliv Rev, 1998, 29:39-49.
9. KUBLIK H, VIDGIEN M T. Nasal delivery systems and their effect on deposition and absorption [J]. Adv Drug Deliv Rev, 1998, 29:157-177.
10. KAVITA K, MAUREEN D D, DOUGLAS R F. Drug transfer through mucus [J]. Adv Drug Deliv Rev, 2001, 48:173-193.
11. HIRAI S, YASHIKI T, MATSUZAWA T, et al. Absorption of drugs from the nasal mucosa of rat[J]. Int J Pharm, 1981, 7:317-327.
12. JIANG X G, CUI J B, FANG X L, et al. Toxicity of drugs on nasal mucocilia and the method of its evaluation[J]. Acta Pharm Sin 1995, 30(11):848-853.
13. TONG Y W, JIN F, HUANG A N. Laboratory investigation of scopolamine hydrobromide nasal spary[J]. Strait Pharm J 2004, 16(4):39-41.
14. ZHAO Y, ZHANG D W, ZHENG A P. Influence of seven absorption enhancers on nasal mucosa-assessment of toxicity[J]. J Peking Univ (Health Science) 2004, 36(4):417-420.
15. LISBETH I. Nasal drug delivery: new developments and strategies [J]. Drug Discov Today, 2002, 23(7):1184-1189.
16. ZHAO B S, LIU Q D. Comparison between borneol-induced opening of blood brain barrier and its pathological opening[J]. Tradit Chin Drug Res Pharmcol 2002, 13(5):287-288.
17. XU W H, WANG H, XU W M. Nasal absorption of ligustrazine and promotion action of synthetic borneol[J]. Chin J Clin Pharmacol Ther 2002, 7(5):434-436.
18. LI Q F, GUO X B. 30 cases of Alzheimer therapy effect of Qishengli tablet[J]. Fujian J Tradit Clin Med 2003, 34 (1): 14.
19. CHEN G S, YE J C, WANG Q. Intranasal Preparations of Huperzine A: China, 1383824A[P]. 2002-12-11.
20. HONG H H, RYOHEL K, RIMA B N, et al. Mechanism of nasal absorption of drugs I: physicochemical parameters influencing the rate of in situ nasal absorption of drugs in rats[J]. J Pharm Sci, 1985, 74 (6):608.
21. ANWAR A H. Intranasal drug delivery[J]. Adv Drug Deliv Rev. 1998, 29(1-2):39-49.